Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial

Clinical Nutrition

Volumn 33, Issue 2, 2014, Pages 198-203

  Asemi, Zatollah ^a   Khorrami Rad, Ashraf ^b   Alizadeh, Sabihe Alsadat ^c   Shakeri, Hossein ^a   Esmaillzadeh, Ahmad ^d,e  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Research and Development of Sekkeh Gaz Company ^*  (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Inflammation; Insulin; Oxidative stress; Plasma glucose; Synbiotic

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INULIN; ISOMALT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREBIOTIC AGENT; PROBIOTIC AGENT; SORBITOL; SWEETENING AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTOBACILLUS; LACTOBACILLUS SPOROGENES; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STEVIA; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

DIABETES; INFLAMMATION; INSULIN; OXIDATIVE STRESS; PLASMA GLUCOSE; SYNBIOTIC;

ADULT; AGED; ANTHROPOMETRY; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIABETES MELLITUS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLUTATHIONE; HUMANS; INSULIN; LACTOBACILLUS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREBIOTICS; PROBIOTICS; SYNBIOTICS; TRIGLYCERIDES; URIC ACID;

EID: 84895438032     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.05.015     Document Type: Article

References (30)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
2. Ruggiero L., Castillo A., Quinn L., Hochwert M. Translation of the diabetes prevention program's lifestyle intervention: role of community health workers. Curr Diab Rep 2012, 12(2):127-137.
3. Haghdoost A.A., Rezazadeh-Kermani M., Sadghirad B., Baradaran H.R. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J 2009, 15:591-599.
4. Ferreira L., Teixeira-de-Lemos E., Pinto F., Parada B., Mega C., Vala H., et al. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm 2010, 2010:592760.
5. Andrews R.C., Cooper A.R., Montgomery A.A., Norcross A.J., Peters T.J., Sharp D.J., et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomised controlled trial. Lancet 2011, 378:129-139.
6. Bengmark S., Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr Hosp 2006, 21(Suppl. 2). 72-84, 73-86.
7. D'Souza A., Fordjour L., Ahmad A., Cai C., Kumar D., Valencia G., et al. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 2010, 67:526-531.
8. Liong M.T., Dunshea F.R., Shah N.P. Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. Br J Nutr 2007, 98:736-744.
9. Rishi P., Mavi S.K., Bharrhan S., Shukla G., Tewari R. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol 2009, 69:222-230.
10. Vitali B., Ndagijimana M., Maccaferri S., Biagi E., Guerzoni M.E., Brigidi P. An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe 2012, 18:386-391.
11. Giamarellos-Bourboulis E.J., Bengmark S., Kanellakopoulou K., Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009, 67:815-821.
12. D'Souza A., Cai C.L., Kumar D., Cai F., Fordjour L., Ahmad A., et al. Cytokines and Toll-like receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation. Am J Transl Res 2012, 4:187-197.
13. Hutt P., Andreson H., Kullisaar T., Vihalemm T., Unt E., Kals J., et al. Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori. Lett Appl Microbiol 2009, 48:797-800.
14. Zhang J.W., Du P., Chen D.W., Cui L., Ying C.M. Effect of viable bifidobacterium supplement on the immune status and inflammatory response in patients undergoing resection for colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2010, 13:40-43.
15. Mohan J.C., Arora R., Khalilullah M. Preliminary observations on effect of Lactobacillus sporogenes on serum lipid levels in hypercholesterolemic patients. Indian J Med Res 1990, 92:431-432.
16. Mantzouridou F., Spanou A., Kiosseoglou V. An inulin-based dressing emulsion as a potential probiotic food carrier. Food Res Int 2012, 46:260-269.
17. Asemi Z., Jazayeri S., Najafi M., Samimi M., Mofid V., Shidfar F., et al. Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Ann Nutr Metab 2012, 60:62-68.
18. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
19. Russo F., Riezzo G., Chiloiro M., De Michele G., Chimienti G., Marconi E., et al. Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Curr Pharm Des 2010, 16:825-831.
20. Ooi L.G., Ahmad R., Yuen K.H., Liong M.T. Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 2010, 93:5048-5058.
21. Liong M.T., Shah N.P. Optimization of cholesterol removal, growth and fermentation patterns of Lactobacillus acidophilus ATCC 4962 in the presence of mannitol, fructo-oligosaccharide and inulin: a response surface methodology approach. J Appl Microbiol 2005, 98:1115-1126.
22. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008, 105:19474-19479.
23. Ouwehand A.C., Tiihonen K., Saarinen M., Putaala H., Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 2009, 101:367-375.
24. Esteve E., Ricart W., Fernandez-Real J.M. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?. Curr Opin Clin Nutr Metab Care 2011, 14:483-490.
25. Sugawara G., Nagino M., Nishio H., Ebata T., Takagi K., Asahara T., et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006, 244:706-714.
26. Usami M., Miyoshi M., Kanbara Y., Aoyama M., Sakaki H., Shuno K., et al. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. J Parenter Enteral Nutr 2011, 35:317-328.
27. Vitali B., Ndagijimana M., Cruciani F., Carnevali P., Candela M., Guerzoni M.E., et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010, 10:4.
28. Voltolini C., Battersby S., Etherington S.L., Petraglia F., Norman J.E., Jabbour H.N. A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 2012, 153:395-403.
29. Kalina U., Koyama N., Hosoda T., Nuernberger H., Sato K., Hoelzer D., et al. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region. Eur J Immunol 2002, 32:2635-2643.
30. Matthews G.M., Howarth G.S., Butler R.N. Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther 2007, 6:1051-1057.